1. Home
  2. CBZ vs ABCL Comparison

CBZ vs ABCL Comparison

Compare CBZ & ABCL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo CBIZ Inc.

CBZ

CBIZ Inc.

HOLD

Current Price

$54.68

Market Cap

3.0B

ML Signal

HOLD

Logo AbCellera Biologics Inc.

ABCL

AbCellera Biologics Inc.

HOLD

Current Price

$12.61

Market Cap

3.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CBZ
ABCL
Founded
1987
2012
Country
United States
Canada
Employees
N/A
N/A
Industry
Business Services
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
3.5B
IPO Year
1996
2020

Fundamental Metrics

Financial Performance
Metric
CBZ
ABCL
Price
$54.68
$12.61
Analyst Decision
Hold
Strong Buy
Analyst Count
3
5
Target Price
$41.33
$8.40
AVG Volume (30 Days)
1.1M
4.5M
Earning Date
04-29-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
134.62
10.91
EPS
2.83
N/A
Revenue
$922,003,000.00
$75,128,000.00
Revenue This Year
$3.92
N/A
Revenue Next Year
$4.12
$21.85
P/E Ratio
$19.30
N/A
Revenue Growth
7.79
160.56
52 Week Low
$24.29
$2.75
52 Week High
$56.93
$13.18

Technical Indicators

Market Signals
Indicator
CBZ
ABCL
Relative Strength Index (RSI) 69.05 66.23
Support Level $54.37 $10.38
Resistance Level $55.12 N/A
Average True Range (ATR) 0.16 0.63
MACD -0.36 -0.04
Stochastic Oscillator 46.94 79.72

Price Performance

Historical Comparison
CBZ
ABCL

About CBZ CBIZ Inc.

CBIZ Inc through its subsidiaries provides professional services advisors to middle-market businesses and organizations nationwide. Its business units have been aggregated into three practice groups: Financial Services, Benefits and Insurance Services, and National Practices. The company provides its services to various industries such as Banking & Financial Services, Commercial Real Estate, Construction, Health Care Manufacturing & Distribution NFP & Education, Private Client Services, Professional Services, Public Sector, and Technology & Life Sciences. It derives the maximum of its revenues from the Financial Services segment and geographically from the United States.

About ABCL AbCellera Biologics Inc.

AbCellera Biologics Inc is a clinical-stage biotechnology company focused on discovering and developing first-in-class antibody medicines for indications with high unmet medical need. It has built a platform for advancing antibody drug programs that the company believes provides it with a competitive advantage in addressing challenging, high-value targets such as complex transmembrane proteins and novel modalities, including multispecifics and antibody-drug conjugates. Organisation's pipeline includes two drug candidates in clinical development, two development candidates in Investigational New Drug (IND/Clinical Trial Application (CTA)-enabling activities, and more than 20 active discovery programs across multiple modalities and indications.

Share on Social Networks: